Sicagen India Ltd Quarterly Results, Profit & Loss, Balance Sheet (SICAGEN) | Stocksigma

Sicagen India Ltd (SICAGEN) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Sicagen India Ltd reported sales of ₹327.95 Cr, operating profit of ₹14.89 Cr (OPM 4.54%) and net profit of ₹8.96 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

SICAGEN quarterly results (₹ Cr)
Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	209.92	251.52	204.54	226.76	264.27	277.91	285.96	327.95
Expenses	203.04	240.91	194.8	217.7	255	266.68	273.55	313.06
Operating Profit	6.88	10.61	9.74	9.06	9.27	11.23	12.41	14.89
OPM	3.28%	4.22%	4.76%	4%	3.51%	4.04%	4.34%	4.54%
Other Income	3.52	2.4	1.92	1.75	2.69	3.11	2.03	1.74
Interest	2.5	3.07	3.04	2.71	2.68	4.29	2.76	2.66
Depreciation	2.39	3.51	2.39	2.37	2.37	3.67	2.39	2.38
Profit before tax	5.51	6.43	6.23	5.73	6.91	6.38	9.29	11.59
Tax	23.77%	38.26%	27.13%	27.75%	28.65%	30.09%	25.4%	22.69%
Net Profit	4.2	3.97	4.54	4.14	4.93	4.46	6.93	8.96
EPS in Rs	1.06	1	1.15	1.05	1.25	1.13	1.75	2.26

SICAGEN profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	836	895	795	891	973	1,156
Expenses	814	869	768	856	934	1,108
Operating Profit	22	27	28	36	40	48
OPM	2.7%	3%	3.5%	4%	4.1%	4.1%
Other Income	0	15	7	10	9	10
Interest	6	9	11	11	13	12
Depreciation	11	11	10	10	11	11
Profit before tax	5	22	14	24	25	34
Tax	112%	18%	24%	29%	28%	-
Net Profit	-1	18	11	17	18	25
EPS in Rs	-0.15	4.5	2.66	4.32	4.57	6.39
Dividend Payout	-162%	13%	23%	23%	22%	-

SICAGEN balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026
Equity Capital	40	40	40	40	40
Reserves	420	444	478	455	488
Borrowings	121	148	164	159	144
Other Liabilities	143	64	148	86	126
Total Liabilities	723	696	830	740	797
Fixed Assets	140	137	140	140	136
CWIP	1	0	1	0	0
Investments	73	79	93	66	83
Other Assets	510	480	596	533	577
Total Assets	723	696	830	740	797

SICAGEN cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-2	15	25	33	44
Cash from Investing Activity	18	-4	-3	-14	-7
Cash from Financing Activity	-18	-13	-20	-17	-19
Net Cash Flow	-2	-3	2	2	18
Free Cash Flow	13	11	22	33	38
CFO/OP	16%	65%	99%	103%	123%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	16	65	99	104	121

SICAGEN ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	107	76	114	94	91
Inventory Days	50	65	67	60	63
Days Payable	60	24	47	20	24
Cash Conversion Cycle	97	117	134	134	130
Working Capital Days	84	85	97	87	82
ROCE	4%	4%	4%	6%	6%